iX Biopharma Advances Rights cum Warrants Issue

iX Biopharma Ltd. (SG:42C) has released an update.

iX Biopharma Ltd. has dispatched notification and application forms to eligible shareholders for its proposed Rights cum Warrants Issue, as previously detailed in announcements and the Offer Information Statement. Shareholders who haven’t received their forms can contact relevant parties for assistance. However, the offer is not available to foreign shareholders due to legal restrictions, and further updates will be provided as necessary.

For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.